SERP
Comments:
THPP-1 is a high quality, selective and potent probe to study PDE10A inhibition in vitro or in vivo. It demonstrated in vivo target engagement and efficacy at a dose (10 mg/kg) that is well tolerated in rats.
The cell line used to determine cellular IC50 was not reported and the IC50 value of 49 nM may vary with cell lines.
THPP-1 showed good PK profile in rats, dogs and rhesus monkeys and efficacy in rats and rhesus schizophrenia models. Of the three species, in vitro potency and in vivo target engagement (by measurement of cGMP striatum level) were only determined in rats so it is unclear what dose is necessary to study THPP-1 pharmacology in other species.
Of note, expression of PDE10A is restricted to the brain and free brain exposure was not determined for the reported in vivo studies. CSF concentration at a single time point was used as a surrogate, and the exposure levels aligns with THPP-1’s high permeability and lack of efflux.
(last updated:
12 Oct 2020 )